Search clinical trials for: PHI-101

Total 7772 results

Aclaris Therapeutics, Inc.

Completed

Study of A-101 for the Treatment of Seborrheic Keratosis

Seborrheic Keratosis

United States
Minerva Neurosciences

Completed

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Healthy Subjects

Ireland
Kythera Biopharmaceuticals

Completed

ATX-101 Abdominoplasty (ATX-101-08-10)

Characteristics of Subcutaneous Fat

United States
Heinrich-Heine University, Duesseldorf
Abiomed Inc.; Profil Clinical Trials Coordination GmbH

Recruiting

Protect Kidney Trial

High-risk Percutaneous Coronary Intervention | Induced Acute Kidney Injury

Germany
Blue Blood Biotech Corp.

Recruiting

Phase II Study of BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

Diabetic Foot Ulcer

Taiwan
ORIC Pharmaceuticals

Terminated

Study of ORIC-101 in Combination With Enzalutamide

Prostatic Neoplasms

United States
Immodulon Therapeutics Ltd

Terminated

A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001

Malignant Melanoma

United Kingdom
Editas Medicine, Inc.

Active, not recruiting

Single Ascending Dose Study in Participants With LCA10

Retinal Degeneration | Eye Diseases, Hereditary | Vision Disorders | Leber Congenital Amaurosis 10 | Inherited Retinal Dystrophies | Retinal Disease | Eye Disorders Congenital

United States
Terns, Inc.

Completed

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

NASH - Nonalcoholic Steatohepatitis

United States
Gate Neurosciences, Inc

Terminated

Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

Major Depressive Disorder | Excessive Sleepiness

United States
R-Tech Ueno, Ltd.

Completed

A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye

Dry Eye

United States
Kythera Biopharmaceuticals

Completed

Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

Healthy

United States
Jubilant Innovation Ltd.

Completed

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
McMaster University
Canadian Institutes of Health Research (CIHR); McMaster Children's Hospital

Completed

Family-centred E-health in Pediatric Weight Management: A Pilot Study

Pediatric Obesity

Canada
Kyverna Therapeutics

Not yet recruiting

A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive
Aerovate Therapeutics

Active, not recruiting

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) (IMPAHCT-FUL)

Pulmonary Arterial Hypertension

United States, Belgium, Spain, Australia, Canada, Singapore, China, Germany, Latvia, Italy, United Kingdom, Portugal, France, Mexico, Argentina, Poland, Chile, Israel, South Africa, Colombia
Novartis Pharmaceuticals

Active, not recruiting

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam (STRENGTH)

Spinal Muscular Atrophy

Japan, Belgium, Spain, Canada, United States, Australia, Italy, France, Netherlands
NYU Langone Health

Completed

Teachers Thriving Together

Social Emotional Competence

United States
Impatients N.V. trading as myTomorrows
Immodulon Therapeutics Ltd

No longer available

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Stage IV | Pancreas Cancer | Pancreatic Cancer Stage III

France, United Kingdom
Spyryx Biosciences, Inc.

Completed

A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis

Cystic Fibrosis

Canada
Kythera Biopharmaceuticals

Completed

To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101

Healthy

United States
MGB Biopharma Limited
Hammersmith Medicines Research; Innovate UK; Cambridge Regulatory Services; Phases... and other collaborators

Completed

Safety, Blood Levels and Effects of MGB-BP-3

Healthy
Kythera Biopharmaceuticals

Completed

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Healthy

United States
EpicentRx, Inc.

Recruiting

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer (KEVLARx)

Oral Mucositis

United States
Xuzhou Central Hospital

Recruiting

DCB Treatment in CTO Guided by IVUS

Coronary Artery Disease

China
Shanghai Zhongshan Hospital
RenJi Hospital; Shanghai 10th People's Hospital; Shanghai General Hospital, Shanghai... and other collaborators

Not yet recruiting

Prospective Acute Myocardial Infarction Data Bank

Acute Myocardial Infarction

China
Daugavpils Regional Hospital
Riga Stradins University

Recruiting

Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome. (iStrategy)

Acute Coronary Syndrome | Cardiac Ischemia

Latvia
Hospices Civils de Lyon

Recruiting

Lyon PJI Retrospective Cohort Study

Bone and Joint Infection

France
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Prevention or Treatment of Arterial Hypotension and Oxygen Cerebral Saturation During Major Abdominal Surgery

Hemodynamic Instability | Hypotension During Surgery

Italy
BrosMed Medical Co., Ltd

Completed

Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI

Patients With Atherosclerotic Plaques in the Coronary Arteries That Require Excision

China
Seung-Jung Park
CardioVascular Research Foundation, Korea

Active, not recruiting

Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS)

Coronary Vessels

Korea, Republic of
Xijing Hospital

Unknown

Optimized Cardioprotection Therapy in Obese Subjects With AMI

Obesity | Myocardial Reperfusion Injury | Acute Myocardial Infarction | Adiposis; Heart

China
Ohio University

Completed

Personal Activity Intelligence (PAI) Pilot (PAI)

Cardiovascular Diseases | Hypertension | Diabetes | Dyslipidemias | Overweight and Obesity

United States
Stentys

Unknown

Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice (WIN)

Coronary Self Expanding Stent

Netherlands, Switzerland
Baim Institute for Clinical Research
Lowell General Hospital; Metro West Medical Center; South Shore Hospital; Brockton... and other collaborators

Completed

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings (MASS COMM)

Coronary Artery Diseases

United States
Ospedale San Donato

Completed

Impact of Critical Limb Ischemia on Long Term Cardiac Mortality in Diabetic Patients Undergoing Percutaneous Coronary Revascularization

Critical Limb Ischemia

Italy
Samara Regional Cardiology Dispensary

Unknown

Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block

Acute Coronary Syndrome

Russian Federation
Ullevaal University Hospital
Helse Innlandet

Unknown

Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction

Acute Myocardial Infarction

Norway
Xijing Hospital

Recruiting

Optimized Cardioprotection Therapy in Obese Subjects With CAD

Obesity | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Adiposis; Heart

China
Fujian Medical University
Pulse Medical Imaging Technology (Shanghai) Co., Ltd

Enrolling by invitation

Quantitative Fractional Ratio-guided Revascularization in STEMI Patients With Multi-vessel Disease

ST Elevation Myocardial Infarction | Multi-Vessel Coronary Artery Stenosis

China
PhytoHealth Corporation

Completed

Effects of PH3 in Diabetic Nephropathy (PH3)

Diabetic Nephropathy

Taiwan
Baim Institute for Clinical Research
Lowell General Hospital; Metro West Medical Center; South Shore Hospital; Brockton... and other collaborators

Completed

The MASS COMM Post-Randomization Phase Cohort Study

Coronary Artery Disease

United States
University of Turku

Completed

Management of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS)

Atrial Fibrillation | Percutaneous Coronary Intervention | Oral Anticoagulation

Finland
Asklepios proresearch
Cordis Corporation

Completed

Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration

Left Ventricular Dysfunction

Germany
Gilead Sciences

Active, not recruiting

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

B-cell Malignancies

United States, United Kingdom, France
Gilead Sciences

Terminated

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
Northeast Normal University

Completed

The Recovering Strategy on Forward Head Posture in Chinese Adolescents: Tai Chi and Manual Therapy

Forward Head Posture

China
National Yang Ming University

Completed

the Effects of Individualized Tai Chi Training on Balance Control in Elderly

Tai Ji
Universität Duisburg-Essen

Completed

Tai Chi for Chronic Non-specific Neck Pain (TaiChiNe)

Neck Pain

Germany
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Assessment of LBR-101 In Chronic Migraine

Chronic Migraine

United States

Search clinical trials for: PHI-101

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations